BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Miyamoto A, Wakabayashi H, Watanabe A. Abnormality in fatty acid composition of gastric mucosal phospholipids in patients with liver cirrhosis and its correction with a polyunsaturated fatty acid-enriched soft oil capsule. J Gastroenterol Hepatol 1997;12:644-52. [DOI: 10.1111/j.1440-1746.1997.tb00528.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Watanabe A, Saito S, Tsuchida T, Higuchi K, Okita M. Low plasma levels of docosahexaenoic acid in patients with liver cirrhosis and its correction with a polyunsaturated fatty acid–enriched soft oil capsule. Nutrition 1999;15:284-8. [DOI: 10.1016/s0899-9007(99)00004-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
2 Kawashima H. Intake of arachidonic acid-containing lipids in adult humans: dietary surveys and clinical trials. Lipids Health Dis 2019;18:101. [PMID: 30992005 DOI: 10.1186/s12944-019-1039-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
3 Pazirandeh S, Ling PR, Ollero M, Gordon F, Burns DL, Bistrian BR. Supplementation of arachidonic acid plus docosahexaenoic acid in cirrhotic patients awaiting liver transplantation: a preliminary study. JPEN J Parenter Enteral Nutr 2007;31:511-6. [PMID: 17947609 DOI: 10.1177/0148607107031006511] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
4 Orihara T, Wakabayashi H, Nakaya A, Fukuta K, Makimoto S, Naganuma K, Entani A, Watanabe A. Effect of Helicobacter pylori eradication on gastric mucosal phospholipid content and its fatty acid composition. J Gastroenterol Hepatol. 2001;16:269-275. [PMID: 11339417 DOI: 10.1046/j.1440-1746.2001.02440.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
5 Ishibashi S, Iwakiri R, Shimoda R, Ootani H, Kawasaki S, Tadano J, Kikkawa A, Ootani A, Oda K, Fujise T, Yoshida T, Tsunada S, Sakata H, Fujimoto K. Normalization of Phospholipids Concentration of the Gastric Mucosa was Observed in Patients with Peptic Ulcer after Eradication of Helicobacter pylori. Helicobacter 2002;7:245-9. [DOI: 10.1046/j.1523-5378.2002.00086.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 González-Périz A, Planagumà A, Gronert K, Miquel R, López-Parra M, Titos E, Horrillo R, Ferré N, Deulofeu R, Arroyo V, Rodés J, Clària J. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 2006;20:2537-9. [PMID: 17056761 DOI: 10.1096/fj.06-6250fje] [Cited by in Crossref: 151] [Cited by in F6Publishing: 150] [Article Influence: 9.4] [Reference Citation Analysis]
7 Wakabayashi H, Orihara T, Nakaya A, Miyamoto A, Watanabe A. Effect of Helicobacter pylori infection on gastric mucosal phospholipid contents and their fatty acid composition. J Gastroenterol Hepatol. 1998;13:566-571. [PMID: 9715397 DOI: 10.1111/j.1440-1746.1998.tb00691.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
8 Nakaya A, Wakabayashi H, Imamura L, Fukuta K, Makimoto S, Naganuma K, Orihara T, Minemura M, Shimizu Y, Nagasawa T, Hamazaki T, Watanabe A. Helicobacter pylori alters n-6 fatty acid metabolism and prostaglandin E2 synthesis in rat gastric mucosal cells. J Gastroenterol Hepatol 2001;16:1197-205. [PMID: 11903735 DOI: 10.1046/j.1440-1746.2001.02541.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]